ROCKAWAY, N.J., Sept. 24, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced…
The approval of QUVIVIQ™, a novel dual orexin receptor antagonist, is based on robust clinical efficacy and safety data, including…
The Laboratory Information System (LIS) market is primarily driven by the increasing demand for automation in laboratory processes, which enhances…
Press release OXFORD BIOMEDICA PLCINTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024 Delivering Pure-Play CDMO Growth Strategy Continued…
Sarclisa approved in the US as the first anti-CD38 therapy in combination with standard-of-care treatment for adult patients with newly…
SAN DIEGO and SAARBRÜCKEN, Saarland, Sept. 19, 2024 /PRNewswire/ -- alwaysAI, a trailblazer in Vision AI technology and Becker Mining…
FORT WASHINGTON, Pa., Sept. 19, 2024 /PRNewswire/ -- Office Practicum, a leading provider of pediatric-focused Electronic Health Record (EHR) and practice…
ALG-055009 dose groups met the primary endpoint with statistically significant reductions in liver fat at Week 12 as measured by…
MELVILLE, N.Y., Sept. 19, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage…
The integrated, easy-to-use platform radically simplifies billing and payments for senior living communities and families. SAN FRANCISCO--(BUSINESS WIRE)--Today August Health…